INVESTORS

Endpoint Health is a precision-first therapeutics company

Endpoint Health is a precision-first therapeutics company backed by top-tier Silicon Valley investors and founded by successful entrepreneurs who built and sold a previous healthcare company to Roche. Founded in 2018, we are on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology.

By combining data science, therapeutics and therapy-guiding tests, Endpoint Health is uniquely built for the new era of precision medicine.

Our vision is a world in which all patients get the best treatment possible for their unique biology and disease.

Events & Presentations

TechCrunch Disrupt
Sept 22 Watch Webcast